Articles
Volume 10 Supplement 4
Controversies in Breast Cancer 2008
Short communications
Controversies in Breast Cancer 2008
Edinburgh, UK
1-2 September 2008
Edited by William R Miller, Mitch Dowsett and James N Ingle
Publication of this supplement was supported in part by unrestricted educational grants from AstraZeneca, Novartis, Pfizer and Roche.
|
Controversies in Breast Cancer 2008 William R Miller Breast Cancer Research 2008, 10(Suppl 4):S1 (18 December 2008) |
|
J Michael Dixon, Monica Morrow Breast Cancer Research 2008, 10(Suppl 4):S2 (18 December 2008) |
|
László Tabar, Peter B Dean Breast Cancer Research 2008, 10(Suppl 4):S3 (18 December 2008) |
|
The utility of conventional and molecular pathology in managing breast cancer D Craig Allred Breast Cancer Research 2008, 10(Suppl 4):S4 (18 December 2008) |
|
How much can improved molecular and pathologic discriminants change local therapy? Monica Morrow Breast Cancer Research 2008, 10(Suppl 4):S5 (18 December 2008) |
|
Lesley Fallowfield, David George Breast Cancer Research 2008, 10(Suppl 4):S6 (18 December 2008) |
|
J Michael Dixon, David A Montgomery Breast Cancer Research 2008, 10(Suppl 4):S7 (18 December 2008) |
|
David A Cameron Breast Cancer Research 2008, 10(Suppl 4):S8 (18 December 2008) |
|
Introduction to sessions on 'Predicting personal risk for breast cancer' Mitch Dowsett Breast Cancer Research 2008, 10(Suppl 4):S9 (18 December 2008) |
|
Assessing individual risk for breast cancer: role of oestrogens and androgens Richard J Santen Breast Cancer Research 2008, 10(Suppl 4):S10 (18 December 2008) |
|
Should lifestyle modifications be promoted to prevent breast cancer? Anthony Howell, Michelle Harvie Breast Cancer Research 2008, 10(Suppl 4):S11 (18 December 2008) |
|
Identification of personal risk of breast cancer: genetics Diana M Eccles Breast Cancer Research 2008, 10(Suppl 4):S12 (18 December 2008) |
|
Assessing risk for breast cancer Jack Cuzick Breast Cancer Research 2008, 10(Suppl 4):S13 (18 December 2008) |
|
Psychosocial aspects of risk appraisal Lesley Fallowfield Breast Cancer Research 2008, 10(Suppl 4):S14 (18 December 2008) |
|
James N Ingle Breast Cancer Research 2008, 10(Suppl 4):S15 (18 December 2008) |
|
By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy V Craig Jordan, Roshani Patel, Joan S Lewis-Wambi, Ramona F Swaby Breast Cancer Research 2008, 10(Suppl 4):S16 (18 December 2008) |
|
Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer James N Ingle Breast Cancer Research 2008, 10(Suppl 4):S17 (18 December 2008) |
|
Markers of endocrine sensitivity Daniel F Hayes Breast Cancer Research 2008, 10(Suppl 4):S18 (18 December 2008) |
|
Identification and mechanisms of endocrine resistance William R Miller Breast Cancer Research 2008, 10(Suppl 4):S19 (18 December 2008) |
|
Integration of endocrine therapy with targeted agents Stephen RD Johnston Breast Cancer Research 2008, 10(Suppl 4):S20 (18 December 2008) |

